S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
15 A.I. Trading Opportunities a Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
15 A.I. Trading Opportunities a Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
3 Free Stock Picks per Day (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
15 A.I. Trading Opportunities a Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
15 A.I. Trading Opportunities a Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
3 Free Stock Picks per Day (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
15 A.I. Trading Opportunities a Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
15 A.I. Trading Opportunities a Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
3 Free Stock Picks per Day (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
15 A.I. Trading Opportunities a Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
15 A.I. Trading Opportunities a Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
3 Free Stock Picks per Day (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
LON:VEC

Vectura Group (VEC) Share Forecast, Price & News

GBX 164.80
0.00 (0.00%)
(As of 10/18/2021)
Compare
Today's Range
164.63
▼
165
50-Day Range
164.80
▼
164.80
52-Week Range
100
▼
176
Volume
203,761 shs
Average Volume
3.37 million shs
Market Capitalization
£1.01 billion
P/E Ratio
8.20
Dividend Yield
23.06%
Price Target
N/A
ProfileChartCompetitorsInsider TradesHeadlinesOptions Chain

VEC stock logo

About Vectura Group (LON:VEC) Stock

Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.

Receive VEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter.

VEC Stock News Headlines

May 17, 2023 | marketwatch.com
Ipratropium Bromide Market Forthcoming Trends and Share Analysis by 2031
May 8, 2023 | marketwatch.com
Latest "Ipratropium Bromide Market" Size Forecast 2023-2031: New Challenges, Drivers, and Restraints
May 27, 2023 | Behind the Markets (Ad)
The 4th Military Revolution is Happening
. There have been 3 military revolutions in the past 100 years. The first was when the tank was invented in 1915. The second was the nuclear bomb in 1945. The third was the "smart bomb" in 1991. Amid the turmoil, there will be many losers. Click here to see how to win instead >>>
May 3, 2023 | marketwatch.com
2023-2030 Targeted Drug Delivery System Market Size (Growth and Outlook) includes Latest Development | with [124 Pages]
April 30, 2023 | marketwatch.com
Nebulizers Market is poised to cross USD 1.9 billion by 2032
April 25, 2023 | marketwatch.com
Ipratropium Bromide Market Manufacturing Cost Structure By 2030
April 22, 2023 | marketwatch.com
2023-2030 Potassium Gluconate Market Size with [96 Pages] includes Market Restraints | New Report by Absolute Reports
April 3, 2023 | finance.yahoo.com
Aerami Therapeutics to Host Virtual Investor Day with Leading Experts in Pulmonary Hypertension as AER-901 (Inhaled Imatinib) Advances Toward Phase 2
May 27, 2023 | Behind the Markets (Ad)
"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
March 28, 2023 | marketwatch.com
Polymers Drug Delivery Market Share and Forecast till 2031
March 28, 2023 | marketwatch.com
Ipratropium Bromide Market Share and Forecast till 2028
March 28, 2023 | marketwatch.com
Asthma and COPD Drugs Market Outlook and Forecast till 2031
March 27, 2023 | marketwatch.com
Oral Drug Delivery Market Growth and Forecast till 2031
March 24, 2023 | marketwatch.com
Medical Suction Catheters Market Size, Share, Growth | Global Report, 2031
March 22, 2023 | marketwatch.com
Bronchodilators Market Trends Business Opportunities, Segments and Industry Forecast By 2031
March 17, 2023 | marketwatch.com
COPD Drugs Market Growth and Forecast till 2028
March 15, 2023 | marketwatch.com
COPD Drugs Market Size 2023 Research Report by Manufacturing Process Analysis and Forecast till 2027
March 14, 2023 | marketwatch.com
Tyrosine Protein Kinase JAK1 Market Size 2023 Research Report by Consumption Analysis and Forecast till 2027
March 10, 2023 | marketwatch.com
Dry Powder Inhaler Market Challenges Analysis, Sales Volume, Share and Forecast Research
February 28, 2023 | marketwatch.com
Dry Powder Inhaler Market to Grow Significantly by Leading Players 2023 to 2028
February 28, 2023 | marketwatch.com
Global Pulmonary Hypertension Drug Market Insights, Emerging Trends and Latest Opportunities 2023 – 2030 By VMReports
February 22, 2023 | uk.finance.yahoo.com
The Global Nebulizer Market size is expected to reach $1.4 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast period
February 22, 2023 | marketwatch.com
Asthma Drugs Market is Booming in Near Future 2023-2028 with Top Countries Data
February 19, 2023 | marketwatch.com
Analyzing The Intelligent Asthma Monitoring Devices Market 2023: Proven Strategies for Significant and Trends by 2028
February 17, 2023 | marketwatch.com
Targeted Drug Delivery System Market 2023 Size Industry, Current Trends, Demand and Size Share Estimation by 2028 with Top Players
February 17, 2023 | marketwatch.com
COPD Drugs Market Outlook 2023 and Forecast to 2028 with Top Countries Data
February 14, 2023 | marketwatch.com
Polymers Drug Delivery Market Outlook 2023 and Forecast to 2028 with Top Countries Data
See More Headlines
Receive VEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:VEC
CUSIP
N/A
CIK
N/A
Web
www.vectura.com
Phone
+44-1249-667700
Fax
N/A
Employees
9,200
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
8.20
Forward P/E Ratio
0.18
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.77
Current Ratio
3.59
Quick Ratio
3.20

Sales & Book Value

Annual Sales
£190.60 million
Price / Sales
5.31
Cash Flow
GBX 13.20 per share
Price / Cash Flow
12.48
Book Value
GBX 91.70 per share
Price / Book
1.80

Miscellaneous

Outstanding Shares
613,892,000
Free Float
N/A
Market Cap
£1.01 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. William Downie (Age 54)
    CEO & Exec. Director
    Comp: $538.92k
  • Mr. Paul Andrew Fry (Age 54)
    CFO & Exec. Director
    Comp: $807k
  • Mr. Anthony Fitzpatrick
    Exec. VP of Operations
  • Dr. Geraldine Venthoye
    Chief Scientific Officer & Exec. VP of Product Devel.
  • Elizabeth Knowles
    VP of Investor Relations
  • Mr. John Murphy (Age 68)
    Gen. Counsel & Company Sec.
  • David Ginivan
    VP of Corp. Communications
  • Ms. Christina Olsen
    Exec. VP of Corp. Strategy & Communications
  • Ms. Joanne Hombal (Age 47)
    Exec. VP of HR
  • Mr. Roger Heerman (Age 48)
    Exec. VP of Commercial & Bus. Devel.

Key Competitors

View All Competitors













VEC Stock - Frequently Asked Questions

How have VEC shares performed in 2023?

Vectura Group's stock was trading at GBX 164.80 at the beginning of 2023. Since then, VEC stock has increased by 0.0% and is now trading at GBX 164.80.
View the best growth stocks for 2023 here.

Is Vectura Group a good dividend stock?

Vectura Group (LON:VEC) pays an annual dividend of GBX 38 per share and currently has a dividend yield of 23.06%. VEC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 189.05%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for VEC.

What other stocks do shareholders of Vectura Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SEB (SKP), BTG (BTG), iRobot (IRBT), Sinclair Pharma (SPH), Sirius Minerals (SXX), Coats Group (COA), Griffin Mining (GFM), HSBC (HSBA) and Inmarsat (ISAT).

What is Vectura Group's stock symbol?

Vectura Group trades on the London Stock Exchange (LON) under the ticker symbol "VEC."

How do I buy shares of Vectura Group?

Shares of VEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Vectura Group's stock price today?

One share of VEC stock can currently be purchased for approximately GBX 164.80.

How much money does Vectura Group make?

Vectura Group (LON:VEC) has a market capitalization of £1.01 billion and generates £190.60 million in revenue each year.

How many employees does Vectura Group have?

The company employs 9,200 workers across the globe.

How can I contact Vectura Group?

Vectura Group's mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The official website for the company is www.vectura.com. The company can be reached via phone at +44-1249-667700.

This page (LON:VEC) was last updated on 5/27/2023 by MarketBeat.com Staff

My Account -